76 related articles for article (PubMed ID: 34996491)
1. INPP5F translocates into cytoplasm and interacts with ASPH to promote tumor growth in hepatocellular carcinoma.
Zhou Q; Lin J; Yan Y; Meng S; Liao H; Chen R; He G; Zhu Y; He C; Mao K; Wang J; Zhang J; Zhou Z; Xiao Z
J Exp Clin Cancer Res; 2022 Jan; 41(1):13. PubMed ID: 34996491
[TBL] [Abstract][Full Text] [Related]
2. ASPH-notch Axis guided Exosomal delivery of Prometastatic Secretome renders breast Cancer multi-organ metastasis.
Lin Q; Chen X; Meng F; Ogawa K; Li M; Song R; Zhang S; Zhang Z; Kong X; Xu Q; He F; Bai X; Sun B; Hung MC; Liu L; Wands J; Dong X
Mol Cancer; 2019 Nov; 18(1):156. PubMed ID: 31694640
[TBL] [Abstract][Full Text] [Related]
3. Transketolase (TKT) activity and nuclear localization promote hepatocellular carcinoma in a metabolic and a non-metabolic manner.
Qin Z; Xiang C; Zhong F; Liu Y; Dong Q; Li K; Shi W; Ding C; Qin L; He F
J Exp Clin Cancer Res; 2019 Apr; 38(1):154. PubMed ID: 30971297
[TBL] [Abstract][Full Text] [Related]
4. IRF5 promotes glycolysis in the progression of hepatocellular carcinoma and is regulated by TRIM35.
Fang Y; Lu ZH; Liu BZ; Li N; Yang MZ; Wang P
J Dig Dis; 2023; 24(8-9):480-490. PubMed ID: 37594849
[TBL] [Abstract][Full Text] [Related]
5. OTUD5 promotes the growth of hepatocellular carcinoma by deubiquitinating and stabilizing SLC38A1.
Yang Y; Jia S; Zhu N; Xiao X; Ma Y; Tu K; Guo Y; Xu Q
Biol Direct; 2024 Apr; 19(1):31. PubMed ID: 38658981
[TBL] [Abstract][Full Text] [Related]
6. TMEM147 aggravates the progression of HCC by modulating cholesterol homeostasis, suppressing ferroptosis, and promoting the M2 polarization of tumor-associated macrophages.
Huang J; Pan H; Sun J; Wu J; Xuan Q; Wang J; Ke S; Lu S; Li Z; Feng Z; Hua Y; Yu Q; Yin B; Qian B; Zhou M; Xu Y; Bai M; Zhang Y; Wu Y; Ma Y; Jiang H; Dai W
J Exp Clin Cancer Res; 2023 Oct; 42(1):286. PubMed ID: 37891677
[TBL] [Abstract][Full Text] [Related]
7. USP40 promotes hepatocellular carcinoma cell proliferation, migration and stemness by deubiquitinating and stabilizing Claudin1.
Wu Q; Qiu Y; Guo J; Yuan Z; Yang Y; Zhu Q; Zhang Z; Guo J; Wu Y; Zhang J; Huang D; Tu K; Hu X
Biol Direct; 2024 Feb; 19(1):13. PubMed ID: 38308285
[TBL] [Abstract][Full Text] [Related]
8. Targeting VPS72 inhibits ACTL6A/MYC axis activity in HCC progression.
Liu F; Liao Z; Qin L; Zhang Z; Zhang Q; Han S; Zeng W; Zhang H; Liu Y; Song J; Chen W; Zhu H; Liang H; Chen X; Zhang B; Zhang Z
Hepatology; 2023 Nov; 78(5):1384-1401. PubMed ID: 36631007
[TBL] [Abstract][Full Text] [Related]
9. Kinetic parameters of human aspartate/asparagine-β-hydroxylase suggest that it has a possible function in oxygen sensing.
Brewitz L; Tumber A; Schofield CJ
J Biol Chem; 2020 Jun; 295(23):7826-7838. PubMed ID: 32107312
[TBL] [Abstract][Full Text] [Related]
10. LANCL1, a cell surface protein, promotes liver tumor initiation through FAM49B-Rac1 axis to suppress oxidative stress.
Huang H; Tsui YM; Ho DW; Chung CY; Sze KM; Lee E; Cheung GC; Zhang VX; Wang X; Lyu X; Ng IO
Hepatology; 2024 Feb; 79(2):323-340. PubMed ID: 37540188
[TBL] [Abstract][Full Text] [Related]
11. Heat shock protein family A member 8 serving as a co-activator of transcriptional factor ETV4 up-regulates PHLDA2 to promote the growth of liver cancer.
Wang S; Wang YF; Yang G; Zhang HH; Yuan HF; Hou CY; Zhao LN; Suo YH; Sun J; Sun LL; Lv P; Sun Y; Zhang NN; Zhang XD; Lu W
Acta Pharmacol Sin; 2023 Dec; 44(12):2525-2536. PubMed ID: 37474643
[TBL] [Abstract][Full Text] [Related]
12. Kinesin family member 18B activates mTORC1 signaling via actin gamma 1 to promote the recurrence of human hepatocellular carcinoma.
Li Q; Sun M; Meng Y; Feng M; Wang M; Chang C; Dong H; Bu F; Xu C; Liu J; Ling Q; Qiao Y; Chen J
Oncogenesis; 2023 Nov; 12(1):54. PubMed ID: 37957153
[TBL] [Abstract][Full Text] [Related]
13. GPR50 Promotes Hepatocellular Carcinoma Progression via the Notch Signaling Pathway through Direct Interaction with ADAM17.
Saha SK; Choi HY; Yang GM; Biswas PK; Kim K; Kang GH; Gil M; Cho SG
Mol Ther Oncolytics; 2020 Jun; 17():332-349. PubMed ID: 32405532
[TBL] [Abstract][Full Text] [Related]
14. Aspartate β-hydroxylase Regulates Expression of
Kanwal M; Smahelova J; Ciharova B; Johari SD; Nunvar J; Olsen M; Smahel M
J Cancer; 2024; 15(5):1138-1152. PubMed ID: 38356711
[No Abstract] [Full Text] [Related]
15. Novel nuclear translocation of inositol polyphosphate 4-phosphatase is associated with cell cycle, proliferation and survival.
Chaudhuri R; Khanna K; Koundinya D; Pattnaik B; Vatsa D; Agrawal A; Ghosh B
Biochim Biophys Acta Mol Cell Res; 2018 Jul; ():. PubMed ID: 30071275
[TBL] [Abstract][Full Text] [Related]
16. ACTR5 controls CDKN2A and tumor progression in an INO80-independent manner.
Xu X; Chan AKN; Li M; Liu Q; Mattson N; Pangeni Pokharel S; Chang WH; Yuan YC; Wang J; Moore RE; Pirrotte P; Wu J; Su R; Müschen M; Rosen ST; Chen J; Yang L; Chen CW
Sci Adv; 2022 Dec; 8(51):eadc8911. PubMed ID: 36563143
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneous Response of Tumor Cell Lines to Inhibition of Aspartate β-hydroxylase.
Kanwal M; Polakova I; Olsen M; Kasi MK; Tachezy R; Smahel M
J Cancer; 2024; 15(11):3466-3480. PubMed ID: 38817852
[No Abstract] [Full Text] [Related]
18. SMYD4 monomethylates PRMT5 and forms a positive feedback loop to promote hepatocellular carcinoma progression.
Zhou Z; Chen Z; Zhou Q; Meng S; Shi J; Mui S; Jiang H; Lin J; He G; Li W; Zhang J; Wang J; He C; Yan Y; Xiao Z
Cancer Sci; 2024 May; 115(5):1587-1601. PubMed ID: 38438251
[TBL] [Abstract][Full Text] [Related]
19. Exploration of prognosis and immunometabolism landscapes in ER+ breast cancer based on a novel lipid metabolism-related signature.
Shen L; Huang H; Li J; Chen W; Yao Y; Hu J; Zhou J; Huang F; Ni C
Front Immunol; 2023; 14():1199465. PubMed ID: 37469520
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
